About GlaxoSmithKline Plc (GSK)
GSK’s business model is based on two pillars: Pharmaceuticals and vaccines. Its pharmaceutical products include medicines to treat various conditions including cancer, diabetes, cardiovascular disease, respiratory disorders, and mental health issues. Vaccines are produced to prevent infectious diseases.
Here are some details about GSK
- GSK’s Products
GSK produces over 150 different products. These include drugs, vaccines, and diagnostics. The company focuses on developing innovative treatments for patients who have serious medical conditions.
- GSK’s Strategy
GSK aims to become the world leader in healthcare innovation. To achieve this goal, the company invests heavily in research and development. GSK spends about 4% of its revenue on R&D.
- GSK’s Corporate Social Responsibility
In 2016, GSK launched a campaign called “Every Life Counts”. The campaign aimed at raising awareness among people about the importance of vaccination. GSK also supports various charities and non-profit organizations.
- GSK reported strong financial performance in 2017. Its net sales grew by 6%. However, its operating profit declined by 10% due to higher costs associated with acquisitions.
- GSK is listed on the London Stock Exchange. The company has a market capitalization of £62.0 billion. Its shares trade under the symbol GSK.
- The company’s annual report was published on April 5th 2018. In the report, the company stated that its net sales increased by 6% year-on-year to €16.9 billion in 2017. Net income rose by 11% to €1.8 billion.
GlaxoSmithKline Plc (GSK)
Please follow us on our homepage for Jobs Today